Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2010 | Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses. | Wen, WH; Wang, SY; Tsai, KC; Cheng, YS; Yang, AS; Fang, JM; Wong, CH | Bioorganic & medicinal chemistry 18(11), 4074-4084 | | | |
2011 | Crystal structure and substrate-binding mode of cellulase 12A from Thermotoga maritima. | Cheng, YS; Ko, TP; Wu, TH; Ma, Y; Huang, CH; Lai, HL; Wang, AHJ; Liu, JR; Guo, RT | Proteins 79(4), 1193-1204 | | | |
2012 | Development of Oseltamivir Phosphonate Congeners as Anti-influenza Agents. | Cheng, TJ; Weinheimer, S; Tarbet, EB; Jan, JT; Cheng, YS; Shie, JJ; Chen, CL; Chen, CA; Hsieh, WC; Huang, PW; Lin, WH; Wang, SY; Fang, JM; Hu, OY; Wong, CH | Journal of medicinal chemistry 55(20), 8657-8670 | | | |
2008 | Domain requirement of moenomycin binding to bifunctional transglycosylases and development of high-throughput discovery of antibiotics. | Cheng, TJ; Sung, MT; Liao, HY; Chang, YF; Chen, CW; Huang, CY; Chou, LY; Wu, YD; Chen, YH; Cheng, YS; Wong, CH; Ma, C; Cheng, WC | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 105(2), 431-6 | | | |
2011 | E339…R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors | Shen, YF; Chen, YH; Chu, SY; Lin, MI; Hsu, HT; Wu, PY; Wu, CJ; Liu, HW; Lin, FY; Lin, G; Hsu, PH; Yang, AS; Cheng, YS; Wu, YT; Wong, CH; Tsai, MD | Proceedings of the National Academy of Sciences of the United States of America 108, 16515-16520 | | | |
2012 | Enhanced activity of Thermotoga maritima cellulase 12A by mutating a unique surface loop. | Cheng, YS; Ko, TP; Huang, JW; Wu, TH; Lin, CY; Luo, W; Li, Q; Ma, Y; Huang, CH; Wang, AHJ; Liu, JR; Guo, RT | Applied microbiology and biotechnology 95(3), 661-669 | | | |
2007 | Gene expression and localization of the epinecidin-1 antimicrobial peptide in the grouper (Epinephelus coioides), and its protection of fish against pathogenic infection | Pan, CY; Chen, JY; Cheng, YS; Chen, CY; Ni, IH; Sheen, JF; Pan, YL; Kuo, CM. | DNA and Cell Biology 26, 403-413 | | | |
2009 | HA-pseudotyped retroviral vector for influenza antagonist screening. | Wang, SY; Su, CY; Lin, M; Huang, SY; Huang, WI; Wang, CC; Wu, YT; Cheng, TJ; Yu, HM; Ren, CT; Wu, CY; Wong, CH; Cheng, YS | Journal of Biomolecular Screening 14(3), 294-302 | | | |
2009 | HA-pseudotyped retroviral vectors for influenza antagonist screening | Wang, SY; Su, CY; Lin, M; Huang, SY; Huang, WI; Wang, CC; Wu, YT; Cheng, TJ; Yu, HM; Ren, CT; Wu, CY; Wong, CH; Cheng, YS | JOURNAL OF BIOMOLECULAR SCREENING 14(3), 294-302 | | | |
2010 | High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. | Su, CY; Cheng, TJ; Lin, MI; Wang, SY; Huang, WI; Lin-Chu, SY; Chen, YH; Wu, CY; Lai, MM; Cheng, WC; Wu, YT; Tsai, MD; Cheng, YS; Wong, CH | Proceedings of the National Academy of Sciences of the United States of America 107(45), 19151-19156 | | | |
2008 | Histamine metabolism influences blood vessel branching by regulating egr-1 transcription factor in zebrafish reg6 mutants | Huang, CC; Huang, CW; Cheng, YS; Yu, J. | BMC Dev. Biol 8, 31-42 | | | |
2008 | In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses. | Su, CY; Wang, SY; Shie, JJ; Jeng, KS; Temperton, NJ; Fang, JM; Wong, CH; Cheng, YS | Antiviral research 79(3), 199-205 | | | |
2010 | In vivo protection provided by a synthetic new alpha-galactosyl ceramide analog against bacterial and viral infections in murine models | Lin, KH; Liang, JJ; Huang, WI; Lin-Chu, SY; Su, CY; Lee, YL; Jan, JT; Lin, YL; Cheng, YS; Wong, CH. | Antimicrobial Agents and Chemotherapy 54(10), 4129-4136 | | | |
2005 | Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters. | Shie, JJ; Fang, JM; Kuo, TH; Kuo, CJ; Liang, PH ; Huang, HJ; Wu, YT; Jan, JT; Cheng, YS; Wong, CH | BIOORGANIC & MEDICINAL CHEMISTRY 13, 5240-5252 | | | |
2022 | Safety Assessment of 3S, 3'S Astaxanthin Derived from Metabolically Engineered K. marxianus | Samuel, SY; Wang, HD; Huang, MY; Cheng, YS; Chen, JR; Li, WH ; Chang, JJ | Antioxidants 11(11), 2288 | | | |
2006 | Screening for HIV protease inhibitors by protection against activity-mediated cytotoxicity in E. coli | Cheng, YS; Lo, KH; Hsu, HH; Shao, YM; Yang, WB; Lin, CH ; Wong, CH | J. Virol. Methods 137, 82-87 | | | |
2011 | Substrate binding of a GH5 endoglucanase from the ruminal fungus Piromyces rhizinflata. | Tseng, CW; Ko, TP; Guo, RT; Huang, JW; Wang, HC; Huang, CH; Cheng, YS; Wang, AHJ; Liu, JR | Acta Crystallographica Section F-Structural Biology and Crystallization Communications 67(Pt 10), 1189-1194 | | | |
2009 | Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus. | Wen, WH; Lin, M; Su, CY; Wang, SY; Cheng, YS; Fang, JM; Wong, CH | Journal of medicinal chemistry 52(15), 4903-4910 | | | |
2015 | Synthesis and inhibitory effects of novel pyrimido-pyrrolo-quinoxalinedione analogues targeting nucleoproteins of influenza A virus H1N1. | Lin, MI; Su, BH; Lee, CH; Wang, ST; Wu, WC; Dangate, P; Wang, SY; Huang, WI; Cheng, TJ; Lin, OA; Cheng, YS; Tseng, YJ; Sun, CM | European journal of medicinal chemistry 102, 477-86 | | | |
2007 | Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity. | Shie, JJ; Fang, JM; Wang, SY; Tsai, KC; Cheng, YS; Yang, AS; Hsiao, SC; Su, CY; Wong, CH | Journal of the American Chemical Society 129(39), 11892-3 | | | |